Announcements Trials

Browse Landscape

Phase

Phase 2 12 Phase 1/2 8 Phase 1 5 Phase NA 2 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 146 Breast Neoplasms 111 Prostatic Neoplasms 59 Neoplasms 54 Multiple Myeloma 54 Lung Neoplasms 49 Neoplasm Metastasis 40 Ovarian Neoplasms 33 Colorectal Neoplasms 32 Parkinson Disease 4, Autosomal Dominant Lewy Body 31 Leukemia, Lymphocytic, Chronic, B-Cell 31 Recurrence 26 Leukemia, Myeloid, Acute 26 Carcinoma, Renal Cell 25 Urinary Bladder Neoplasms 23 Triple Negative Breast Neoplasms 21 Small Cell Lung Carcinoma 21 Myasthenia Gravis 21 Endometrial Neoplasms 21 Carcinoma, Hepatocellular 21 Lymphoma, Large B-Cell, Diffuse 20 Squamous Cell Carcinoma of Head and Neck 19 Melanoma 18 Lymphoma, Follicular 18 Nasopharyngeal Carcinoma 17 Fallopian Tube Neoplasms 16 Pancreatic Neoplasms 15 Non-Muscle Invasive Bladder Neoplasms 15 Brain Neoplasms 15 Stomach Neoplasms 14

Interventions

avelumab 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Merkel Cell × 90 days × Clear all

NCT03271372 2026-05-12

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡